VHL - VON HIPPEL-LINDAU SYNDROME
Clinical trials for VHL - VON HIPPEL-LINDAU SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VHL - VON HIPPEL-LINDAU SYNDROME trials appear
Sign up with your email to follow new studies for VHL - VON HIPPEL-LINDAU SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shrinks VHL kidney tumors in early trial
Disease control OngoingThis study tests a drug called belzutifan (PT2977) in 50 people with VHL syndrome who have kidney cancer. The goal is to see if the drug can shrink tumors. Participants take the drug by mouth and are monitored for response. This is a phase 2 trial, meaning it is still being studi…
Matched conditions: VHL - VON HIPPEL-LINDAU SYNDROME
Phase: PHASE2 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
VHL patients share their struggles in new survey study
Knowledge-focused OngoingThis study asks 200 adults with von Hippel-Lindau syndrome (VHL) to fill out an online survey about their quality of life, emotional well-being, and difficulties getting care. No treatments or tests are given—just questions to learn what patients experience. The goal is to better…
Matched conditions: VHL - VON HIPPEL-LINDAU SYNDROME
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated May 17, 2026 11:36 UTC